文献速递肺栓塞与肺血管病

肺动脉高压功能分级自评量表的初步评估:一种以患者为中心的测量工具

Initial Evaluation of Pulmonary Hypertension Functional Classification Self-Report Measurement Properties: A Patient-Focused Measure.
PubMed 文献 · Chest · 2025-11-27

本研究在89例肺动脉高压患者中评估患者自报的PH-FC-SR与医生评估的WHO功能分级的一致性及结构效度。结果显示近半数分级匹配,且PH-FC-SR与症状及健康相关生活质量的相关性均强于WHO-FC。提示PH-FC-SR能更好地从患者视角反映功能状态。

要点

  • PH-FC-SR与WHO-FC仅约半数匹配,类内一致性有限。
  • PH-FC-SR与EmPHasis-10及SF-36v2躯体维度相关性较强。
  • PH-FC-SR与患者报告结局的相关性均强于医生评估的WHO-FC。

核心结论

  • 患者自报的PH-FC-SR与肺动脉高压症状及健康相关生活质量的相关性比医生评估的WHO-FC更强。

研究设计与样本

  • 研究为在线问卷调查,纳入来自Cleveland Clinic和Mayo Clinic的89例肺动脉高压成人患者(WSPH分组1-5)。

主要发现

  • PH-FC-SR与WHO-FC分级完全匹配者近半数,其中I级匹配68.8%(n=11)、II级匹配36.8%(n=14)、III级匹配56.3%(n=18)。
  • PH-FC-SR与多数研究特定PH症状条目的相关性为中等(|r|≥0.30至<0.70)。
  • PH-FC-SR与EmPHasis-10相关性为|r|=0.81,与SF-36v2躯体功能、角色躯体及躯体成分汇总的相关性分别为|r|=0.76、0.75、0.73。
  • PH-FC-SR与所有患者报告结局指标的相关性均大于WHO-FC。

临床怎么用

  • PH-FC-SR可作为从患者视角评估肺动脉高压功能分级的补充工具,尤其关注症状负担与生活质量时。

局限性

  • 样本量较小(89例),以女性、白种人及肺动脉高压(55.1%)为主,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary hypertension (PH) is characterized by a high mean pulmonary artery pressure and an impaired health-related quality of life. The Pulmonary Hypertension Functional Class Self-Report (PH-FC-SR), a patient-reported version of the World Health Organization Functional Classification (WHO-FC), was developed to assess PH functional class from the patient perspective. RESEARCH QUESTION: Is the PH-FC-SR a suitable measure for capturing the patient perspective on PH functional class? STUDY DESIGN AND METHODS: Adults with PH (World Symposium on Pulmonary Hypertension [WSPH] groups 1-5) recruited from the Cleveland Clinic and Mayo Clinic completed an online survey capturing demographic information, the PH-FC-SR, study-specific PH symptom questions, and additional patient-reported outcome measures (the EmPHasis-10, and the SF-36 Health Survey Version 2 [SF-36v2]). Clinician-reported WHO-FC data were collected via a telehealth/in-person clinical visit. Concordance of the PH-FC-SR with the WHO-FC was investigated in addition to construct validity. RESULTS: The study sample included 89 patients (mean age, 61.5 years) who were mostly female (66.3%) and White (87.6%) and predominantly with pulmonary arterial hypertension (55.1%). Distribution of PH-FC-SR/WHO-FC scores indicated diversity in symptom severity. Nearly one-half of the PH-FC-SR and WHO-FC classifications matched, with concordance observed for class I (n = 11; 68.8%), class II (n = 14; 36.8%), and class III (n = 18; 56.3%). Correlations between the PH-FC-SR and most study-specific PH symptom items were moderate in magnitude (|r| ≥ 0.30 to < 0.70) and strong between the PH-FC-SR and EmPHasis-10 (|r| = 0.81) and some SF-36v2 subscales (Physical Functioning [|r| = 0.76], Role-physical [|r| = 0.75], and Physical Component Summary [|r| = 0.73]). The PH-FC-SR had larger correlations than the WHO-FC for all patient-reported outcome measures. INTERPRETATION: The patient-reported PH-FC-SR was shown to be more strongly associated with PH symptoms and health-related quality of life than the physician-assigned WHO-FC.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Crawford R, McLeod L, Yarr S, et al. Initial Evaluation of Pulmonary Hypertension Functional Classification Self-Report Measurement Properties: A Patient-Focused Measure. Chest. 2025. PMID: 41318058. doi:10.1016/j.chest.2025.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。